Adult Brainstem Gliomas
- 1 March 2012
- journal article
- review article
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 17 (3), 388-397
- https://doi.org/10.1634/theoncologist.2011-0335
Abstract
Brainstem gliomas are uncommon in adults and account for only 1%-2% of intracranial gliomas. They represent a heterogeneous group of tumors that differ from those found in their pediatric counterparts. In adults, a low-grade phenotype predominates, which is a feature that likely explains their better prognosis compared to that in children. Because biopsies are rarely performed, classifications based on the radiological aspect of magnetic resonance imaging results have been proposed to establish treatment strategies and to determine outcomes: (a) diffuse intrinsic low-grade, (b) enhancing malignant glioma, (c) focal tectal gliomas, and (d) exophytic gliomas. Despite significant advances in neuroradiology techniques, a purely radiological classification remains imperfect in the absence of a histological diagnosis. Whereas a biopsy may often be reasonably avoided in the diffuse nonenhancing forms, obtaining histological proof seems necessary in many contrast-enhanced brainstem lesions because of the wide variety of differential diagnoses in adults. Conventional radiotherapy is the standard treatment for diffuse intrinsic low-grade brainstem gliomas in adults (the median survival is 5 years). In malignant brainstem gliomas, radiotherapy is the standard treatment. However, the possible benefit of combined radiotherapy and chemotherapy (temozolomide or other agents) has not been thoroughly evaluated in adults. The role of anti-angiogenic therapies in brainstem gliomas remains to be defined. A better understanding of the biology of these tumors is of primary importance for identifying homogeneous subgroups and for improving therapy options and outcomes.Keywords
This publication has 63 references indexed in Scilit:
- A phase II study of gefitinib and irradiation in children with newly diagnosed brainstem gliomas: A report from the Pediatric Brain Tumor ConsortiumNeuro-Oncology, 2011
- Characterization and outcomes of infratentorial malignant glioma: A population-based study using the Surveillance Epidemiology and End-Results databaseRadiotherapy and Oncology, 2010
- Prospective collection of tissue samples at autopsy in children with diffuse intrinsic pontine gliomaCancer, 2010
- Lack of Efficacy of Bevacizumab Plus Irinotecan in Children With Recurrent Malignant Glioma and Diffuse Brainstem Glioma: A Pediatric Brain Tumor Consortium StudyJournal of Clinical Oncology, 2010
- DTI fiber tracking to differentiate demyelinating diseases from diffuse brain stem gliomaNeuroImage, 2010
- Metabolism of diffuse intrinsic brainstem gliomas in childrenNeuro-Oncology, 2008
- Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: A Pediatric Brain Tumor Consortium report1Neuro-Oncology, 2007
- Adult brainstem gliomasNeurology, 1998
- Hyperfractionated irradiation for adults with brainstem gliomasInternational Journal of Radiation Oncology*Biology*Physics, 1991
- Stereotaxic suboccipital transcerebellar biopsy of pontine mass lesionsJournal of Neurosurgery, 1989